US Chamber of Commerce criticises Canada’s ‘promise doctrine’

23-03-2017

The US Chamber of Commerce has urged the Canadian government to address its ‘promise utility doctrine’, claiming that it “dramatically undermines legal certainty for medical innovators in Canada”.


Canada, promise doctrine, patent, NAFTA, ICSID, Eli Lilly, innovation, PhRMA, US Chamber of Commerce

More on this story

Calls for NAFTA IP chapter to be abolished
26-01-2018

LSIPR